Ribonucleic Acid (RNA) Sequencing Market Report 2026

Ribonucleic Acid (RNA) Sequencing Market Overview

• Ribonucleic Acid (RNA) Sequencing market size has reached to $3.96 billion in 2025 • Expected to grow to $9.63 billion in 2030 at a compound annual growth rate (CAGR) of 18.8% • Growth Driver: Role Of Precision Medicine In Driving The RNA Sequencing Market • Market Trend: Automation Advancements Driving Innovation In RNA Sequencing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ribonucleic Acid (RNA) Sequencing Market?

Ribonucleic acid (RNA) sequencing refers to a technique that uses next-generation sequencing to reveal the presence and quantity of RNA molecules in a biological sample, providing a snapshot of gene expression in the sample. It enables researchers to study gene expression, identify novel transcripts, and understand RNA processing. The main product types of ribonucleic acid (RNA) sequencing are instruments, reagents and kits, and software. Instruments in RNA sequencing refer to the physical tools and machinery used to analyze RNA molecules, such as sequencers and polymerase chain reaction machines. They are essential for processing and examining RNA samples accurately. The technologies included are single molecule based sequencing, sequence by synthesis technology, nanopore sequencing technology, and ion torrent semiconductor sequencing used in several applications such as diagnostics, drug discovery, translational medicine, and others by end users such as research and academia, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

What Is The Ribonucleic Acid (RNA) Sequencing Market Growth Forecast?

The ribonucleic acid (rna) sequencing market size is expected to see rapid growth in the next few years. It will grow to $9.63 billion in 2030 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising investments in transcriptomics research, expansion of clinical diagnostic sequencing, growing integration of ai-driven data analysis, increasing focus on personalized therapeutics. Major trends in the forecast period include increasing adoption of single-cell rna sequencing, rising use of high-throughput sequencing platforms, growing integration of advanced bioinformatics tools, expansion of clinical and translational research applications, enhanced focus on data accuracy and reproducibility.

Global Ribonucleic Acid (RNA) Sequencing Market Segmentation

1) By Product Type: Instruments, Reagents And Kits, Software 2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing 3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications 4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments 2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits 3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

What Is The Driver Of The Ribonucleic Acid (RNA) Sequencing Market?

An increasing focus on precision medicine is expected to propel the growth of the ribonucleic acid (RNA) sequencing market going forward. Precision medicine or personalized medicine is an innovative approach to medical treatment and prevention that considers individual variability in genes, environment, and lifestyle for each person. Personalized medicine has the potential to provide more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. RNA sequencing technologies are utilized to determine the sequence and quantify the expression levels of RNA molecules within a sample. It enables comprehensive analysis of transcriptomes and insights into gene expression patterns, alternative splicing events, and RNA modifications. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, increasing focus on precision medicine drives the ribonucleic acid (RNA) sequencing industry.

Key Players In The Global Ribonucleic Acid (RNA) Sequencing Market

Major companies operating in the ribonucleic acid (rna) sequencing market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Merck KGaA, Becton Dickinson And Company, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, QIAGEN NV, Tecan Genomics Inc, BGI Genomics Co Ltd, Takara Bio Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences Of California Inc, Macrogen Inc, Standard BioTools Inc, CD Genomics, Genewiz Inc, Novogene Co Ltd, GENEWIZ Germany GmbH, Azenta Life Sciences

Global Ribonucleic Acid (RNA) Sequencing Market Trends and Insights

Major companies operating in the ribonucleic acid (RNA) sequencing market focus on RNA next-generation sequencing assay to improve patient care through data-driven insights and precision medicine. RNA next-generation sequencing assay is a next-generation exome sequencing platform that leverages advanced genomic sequencing technologies to analyze a patient's entire exome. For instance, in June 2023, Tempus, a US-based precision medicine technology company, unveiled its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, designed for solid tumors, offers a comprehensive analysis of the entire transcriptome, highlighting clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with a specific interest in RNA fusions or altered splicing and providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.

What Are Latest Mergers And Acquisitions In The Ribonucleic Acid (RNA) Sequencing Market?

In January 2024, Parse Biosciences, a US-based biotechnology company focused on developing innovative solutions for biological research and diagnostics, acquired Biomage for an undisclosed amount. Through this acquisition, Parse Biosciences will be able to integrate Biomage's powerful data analysis tools, including its Cellenics cloud-based platform, into Parse's Evercode combinatorial barcoding technology. Biomage Ltd. is a UK-based company specializing in RNA sequencing and analysis software and services.

Regional Outlook

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ribonucleic Acid (RNA) Sequencing Market?

The ribonucleic acid (RNA) sequencing market consists of revenues earned by entities by providing services such as library preparation, RNA extraction, fragmentation, reverse transcription, adapter ligation, sequencing, data analysis, bioinformatics support, consultation and experimental design, quality control, sample preparation services, gene cloning, genotyping and mutation detection, and pathogen detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) sequencing market also includes sales of library preparation kits, RNA extraction kits, quantification kits, polymerase chain reaction (PCR) instruments, pipette tips, tubes, and plates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ribonucleic Acid (RNA) Sequencing Market Report 2026?

The ribonucleic acid (rna) sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.